Literature DB >> 11235937

A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.

S Saxena1, A Winograd, J J Dunkin, K Maidment, R Rosen, T Vapnik, G Tarlow, A Bystritsky.   

Abstract

BACKGROUND: Although body dysmorphic disorder (BDD) has many features in common with obsessive-compulsive disorder (OCD) and is frequently comorbid with OCD, few studies have directly compared the 2 disorders. Although BDD and OCD respond to similar medications and cognitive-behavioral therapy (CBT), their response to treatment has never been directly compared.
METHOD: We studied 107 consecutive patients with DSM-III-R OCD (N = 96) or BDD (N = 11) treated openly for 6 weeks with intensive CBT, medication, and psychosocial rehabilitation, in a specialized partial hospitalization program for severely ill OCD patients. All patients were assessed, before and after treatment, with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A), and Global Assessment Scale (GAS). Retrospectively, we compared the clinical characteristics, symptom severity, and response to treatment of BDD patients with those of OCD patients.
RESULTS: BDD patients and OCD patients had similar sex ratio, age, treatment duration, prevalence of comorbid major depression, and pretreatment Y-BOCS and GAS scores. BDD patients had significantly higher pretreatment HAM-D and HAM-A scores. The proportions of patients treated with serotonin reuptake inhibitors and antipsychotics did not differ between groups. Both groups improved with treatment, with significant (p < .001) changes in Y-BOCS, HAM-D, HAM-A, and GAS scores. Change in Y-BOCS did not differ between groups, but changes in HAM-D and HAM-A were significantly greater in BDD patients than in OCD patients.
CONCLUSION: While BDD may be associated with greater severity of depressive and anxiety symptoms than OCD, this study suggests that BDD may respond to intensive, multimodal treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11235937     DOI: 10.4088/jcp.v62n0114b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard
Journal:  Ann Clin Psychiatry       Date:  2006 Oct-Dec       Impact factor: 1.567

3.  Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.

Authors:  Katharine A Phillips; Elizabeth R Didie; William Menard
Journal:  J Affect Disord       Date:  2006-08-07       Impact factor: 4.839

4.  Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders.

Authors:  Katharine A Phillips; Anthony Pinto; William Menard; Jane L Eisen; Maria Mancebo; Steven A Rasmussen
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

Review 5.  [Body dysmorphic disorder : Anxiety about deformity].

Authors:  T Gieler; E Brähler
Journal:  Hautarzt       Date:  2016-05       Impact factor: 0.751

6.  Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.

Authors:  Ozcan Uzun; Barbaros Ozdemir
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

7.  Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.

Authors:  Katharine A Phillips; Jason M Siniscalchi; Susan L McElroy
Journal:  Psychiatr Q       Date:  2004

8.  Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.

Authors:  Michelle Conroy; William Menard; Kathryn Fleming-Ives; Poonam Modha; Hilary Cerullo; Katharine A Phillips
Journal:  Gen Hosp Psychiatry       Date:  2008 Jan-Feb       Impact factor: 3.238

9.  Insight in obsessive compulsive disorder and body dysmorphic disorder.

Authors:  Jane L Eisen; Katharine A Phillips; Meredith E Coles; Steven A Rasmussen
Journal:  Compr Psychiatry       Date:  2004 Jan-Feb       Impact factor: 3.735

10.  Anxiety and Shame as Risk Factors for Depression, Suicidality, and Functional Impairment in Body Dysmorphic Disorder and Obsessive Compulsive Disorder.

Authors:  Hilary Weingarden; Keith D Renshaw; Sabine Wilhelm; June P Tangney; Jennifer DiMauro
Journal:  J Nerv Ment Dis       Date:  2016-11       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.